Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001615774-17-004577
Filing Date
2017-08-21
Accepted
2017-08-18 18:54:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G s107266_sc13g.htm SC 13G 29423
  Complete submission text file 0001615774-17-004577.txt   30718
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-38071 | Film No.: 171041955
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 110 W. GEORGE BURNS ROAD SUITE D-4018 LOS ANGELES CA 90048
Business Address
EDDLEMAN ROY T (Filed by) CIK: 0001270264 (see all company filings)

Type: SC 13G